Search - tctmd.com

Displaying 21 - 38 of 38

Sort: Relevancy | Date

The LOTUS TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

The LOTUS TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Program Update: The LOTUS TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Ted Feldman

June 22, 2018

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

January 05, 2018

The Biggest News of 2017: TCTMD’s Top 10

News Daily News

The Biggest News of 2017: TCTMD’s Top 10

January 01, 2018

Lotus Valve’s Return to Market in Europe Sees Further Delays

News Daily News

Lotus Valve’s Return to Market in Europe Sees Further Delays

November 29, 2017

LOTUS TAVR – Technology Review (Including EDGE) and Clinical Program Updates

Presentation TCT 2017

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Presenter: Michael J. Reardon

October 31, 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

September 27, 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

June 16, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

May 16, 2017

News Daily News

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Michael O'Riordan

March 30, 2017

TCTMD’s Top 10 Most Popular Stories for February 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

March 01, 2017

My Evolving Clinical Experience: From Lotus to Edge

Presentation JIM 2017

My Evolving Clinical Experience: From Lotus to Edge

Presenter: Giuseppe Tarantini

February 24, 2017

Boston Scientific Recalls All Lotus Valves, Including Lotus with Depth Guard

News Daily News

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Michael O'Riordan

February 23, 2017

Lotus TAVR Device with Depth Guard Reduces Risk of Pacemaker Implantation

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Daily News

Boston Scientific Announces Fix for Lotus Edge TAVR Device Following Implantation ‘Pause’

January 11, 2017

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Presentation TCT 2016

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman

November 01, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.